Why did 4549.T stock jump on 24 Feb 2026?

4549.T stock rose on heavy volume after reports of stronger diagnostic kit demand and sector inflows. Short-covering and momentum in Healthcare also amplified gains. Confirming company filings or guidance will clarify the primary driver.

Is 4549.T stock overvalued after the rally?

At **JPY 3300.00** the P/E is **26.10** and RSI is **81.40**, indicating short-term overbought conditions. Meyka's yearly forecast is **JPY 2186.41**, which implies downside, so many investors view the post-rally price as rich without fresh fundamentals.

What are realistic near-term price targets for 4549.T stock?

We frame targets as Bear **JPY 2200.00**, Base **JPY 2600.00**, and Bull **JPY 4000.00**, based on P/E, PB and cash metrics. Adjust targets as new earnings or guidance arrive.

How does Meyka AI rate 4549.T stock?

Meyka AI rates 4549.T with a score out of 100 at **69.94**, Grade **B**, suggestion **HOLD**. The grade reflects benchmark, sector, growth, metrics and analyst inputs; it is informational and not investment advice.

JP Stocks

Eiken Chemical Co., Ltd. (4549.T JPX) up 29.62% at close 24 Feb 2026: reassess 4549.T stock outlook

ByDanny Kontos February 24, 2026February 24, 2026

Eiken Chemical Co., Ltd. (4549.T) closed the JPX session on 24 Feb 2026 at JPY 3300.00, up 29.62% on a volume of 767,000.00 shares. The move made 4549.T stock the top gainer on the Tokyo board at market close and pushed price well above its 50-day average of JPY 2475.00. Investors reacted to a mix of stronger-than-expected diagnostic demand and active trading, while sector momentum in Healthcare supported the rally. We examine what changed, how valuation looks at this level, and what analysts and our models now project for 4549.T stock.